Atossa Therapeutics, Inc. (ATOS) vs Seres Therapeutics, Inc. (MCRB)
A side-by-side comparison of Atossa Therapeutics, Inc. and Seres Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ATOS
Atossa Therapeutics, Inc.
$2.46HealthcareDelayed quote: Oct 6, 2026, 11:55 AM EDT
MCRB
Seres Therapeutics, Inc.
$2.81HealthcareDelayed quote: Oct 6, 2026, 11:51 AM EDT
Total return — ATOS vs MCRB
growth of $100 · dividends reinvested · last 10yATOS -99.3% (-39.4%/yr)MCRB -98.8% (-35.7%/yr)MCRB compounded faster over this window
ATOS MCRB
ATOS vs MCRB: by the numbers
- •MCRB is the larger company ($27M vs $25M market cap).
- •Both run net losses; ATOS's is the smaller (0.00% vs -1192.94% net margin).
Metrics side by side
Valuation
| Metric | ATOS | MCRB |
|---|---|---|
| P/S ratio | N/A | 14.45 |
| P/B ratio | 0.91 | 0.79 |
Profitability
| Metric | ATOS | MCRB |
|---|---|---|
| Gross margin | 0.00% | -423.83% |
| Operating margin | 0.00% | -11910.14% |
| Net margin | 0.00% | -1192.94% |
| ROE | -140.55% | -65.05% |
| ROIC | -146.30% | -103.04% |
Growth (annualized)
| Metric | ATOS | MCRB |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -42.51% |
| Total return CAGR (5Y) | -44.50% | -53.37% |
Frequently asked
- How have ATOS and MCRB total returns compared?
- Over the past 10 years, ATOS delivered -39.47% and MCRB delivered -35.85% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.